TrialInvestigational new drugs2019

The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer.

Giandomenico Roviello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.